Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Neoplasia (New York, N.Y.)
|
February 3, 2025
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Seema Chugh, Jean C Tien, Jennifer Hon, et al.
Histopathology
|
December 25, 2019
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature
Eman Abdulfatah, John M Kennedy, Khaled Hafez, et al.
The American Journal of Surgical Pathology
|
November 23, 2023
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT
Xiao-Ming Wang, Rahul Mannan, Yuping Zhang, et al.
Cell Reports. Medicine
|
March 25, 2026
Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors
Yizhi Cao, Caleb Cheng, Yitong Yin, et al.
Medical Oncology (Northwood, London, England)
|
February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome
Eman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
Human Pathology
|
December 29, 2022
Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma
Rahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer
Jie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
Kelly L Harms, Lili Zhao, Bryan Johnson, et al.
Nature Communications
|
June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
Josh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Science (New York, N.Y.)
|
June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity
Sanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Neoplasia (New York, N.Y.)
|
February 3, 2025
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Seema Chugh, Jean C Tien, Jennifer Hon, et al.
Histopathology
|
December 25, 2019
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature
Eman Abdulfatah, John M Kennedy, Khaled Hafez, et al.
The American Journal of Surgical Pathology
|
November 23, 2023
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT
Xiao-Ming Wang, Rahul Mannan, Yuping Zhang, et al.
Cell Reports. Medicine
|
March 25, 2026
Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors
Yizhi Cao, Caleb Cheng, Yitong Yin, et al.
Medical Oncology (Northwood, London, England)
|
February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome
Eman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
Human Pathology
|
December 29, 2022
Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma
Rahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer
Jie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
Kelly L Harms, Lili Zhao, Bryan Johnson, et al.
Nature Communications
|
June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
Josh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Science (New York, N.Y.)
|
June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity
Sanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Page
of 9